Sunil Parikh, M.D., M.P.H.
Assistant Adjunct Professor
sparikh@medsfgh.ucsf.edu

Mailing Address:
San Francisco General Hospital
1001 Potrero Avenue, Building 30, Room 3400
San Francisco, CA 94110

Office Location:
San Francisco General Hospital, Box 0811

Research Interests:
Host genetics and susceptibility to malaria; Pharmacogenomics of antimalarials; Innate immune responses to malaria; Effect of HIV-1 Protease inhibitors on the malaria parasite

Select Publications:

Nsobya SL*, Parikh S*, Kironde F, Lubega G, Kamya MR, Rosenthal PJ, Dorsey G.  Molecular evaluation of the natural history of asymptomatic malaria in Ugandan children.  The Journal of Infectious Diseases 2004; 189(12):2220-6

Parikh S, Dorsey G, Rosenthal PJ.  Host polymorphisms and the incidence of uncomplicated malaria in Ugandan Children.  Am J Trop Med Hygiene 2004; 71(6):  750-53

Parikh S, Gut J, Istvan E, Goldberg DJ, Havlir D, Rosenthal PJ.  Antimalarial Activity of HIV-1 Protease Inhibitors.  Antimicrobial Agents and Chemotherapy, 2005; 49(7)

Parikh S, Sijwali P, Liu Gut J, Goldberg DJ, Rosenthal PJ. Plasmodium falciparum knockout parasites display different effects when treated with HIV-1 protease inhibitors versus the aspartic protease inhibitor pepstatin. Antimicrobial Agents and Chemotherapy 2006; 50(6)

Parikh S, Quedraogo JB, Goldstein JA, Rosenthal PJ, Kroetz DL. Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: Implications for malaria treatment in Africa. Clinical Pharmacology and Therapeutics; advanced online publication, March 12, 2007

Education and Training:

MD, Johns Hopkins University School of Medicine, Baltimore, MD, 1994-1998

Internal Medicine Residency, Beth Israel Deaconess Medical Center, Boston, MA, 1998-2001

Infectious Disease Fellowship, University of California, San Francisco

Masters in Public Health (Epidemiology and Biostatistics), University of California, Berkeley, 2004-2005